| Ms Laura Ashley Treat, MED, LPC | |
|
1125 E Polston Ave Suite A, Post Falls, ID 83854 | |
| (208) 457-1540 | |
| (208) 773-2811 |
| Full Name | Ms Laura Ashley Treat |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1125 E Polston Ave Suite A, Post Falls, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285888032 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | LCPC-4722 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Laura Ashley Treat, MED, LPC 1125 E Polston Ave Suite A, Post Falls, ID 83854 Ph: () - | Ms Laura Ashley Treat, MED, LPC 1125 E Polston Ave Suite A, Post Falls, ID 83854 Ph: (208) 457-1540 |
News Archive
Demyelinating diseases, such as multiple sclerosis (MS), are frequently associated with the progressive loss of vision. The retinal nerve damage is thought to be caused by immune system-mediated inflammation; however, other demyelinating disorders, such as Pelizaeus-Merzbacher disease, do not involve the immune system, suggesting that there are other causes of retinal nerve damage.
A study has revealed a drug target called the mitoNEET cell protein, which determines how materials are transported from the mitochondria to the rest of the cell.
Results of the landmark RE-LY(R) Trial (Randomized Evaluation of Long term anticoagulant therapy) demonstrate that atrial fibrillation (AF) patients taking PRADAX(R) (dabigatran etexilate) 150mg twice daily (BID) significantly reduced their risk of stroke and systemic embolism by 34 per cent (p less than 0.001) as compared to patients well-controlled on warfarin, without increasing the risk of major bleeding.
Dr. Reddy's Laboratories, announced today that the U.S. Food and Drug Administration has approved ZEMBRACESymTouch (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with or without aura, in adults who are inadequately managed with existing treatment regimens.
› Verified 9 days ago
Krista Gordon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 570 S Clearwater Loop Ste B, Post Falls, ID 83854 Phone: 208-777-2169 Fax: 208-777-2189 | |
Dr. Peter Scott Geissler, M.D., PH.D. Counselor Medicare: Not Enrolled in Medicare Practice Location: 784 S Clearwater Loop Ste 4067, Post Falls, ID 83854 Phone: 208-219-5285 | |
Michael D Garcia, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1700 E Schneidmiller Ave, Post Falls, ID 83854 Phone: 208-619-0190 | |
Christopher Wright, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3553 E Jordan Dr, Post Falls, ID 83854 Phone: 208-818-4298 | |
Tanya Wenig, LPC Counselor Medicare: Medicare Enrolled Practice Location: 1602 E Seltice Way, Suite D, Post Falls, ID 83854 Phone: 208-619-0190 Fax: 208-619-0195 | |
Eve Adams, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1125 E Polston Ave Ste A, Post Falls, ID 83854 Phone: 208-457-1540 | |
Jeffrey James Sitek, MA ED., LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1125 E. Polston Ave, Suite A, Post Falls, ID 83854 Phone: 208-457-1540 Fax: 208-457-1202 |